Cargando…
Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy
Objective: This study aimed to determine the clinicopathological characteristics of cancer-associated venous thromboembolism (CAT-VTE). Methods: A total of 47 cases of lethal pulmonary thromboembolism (PTE) with active cancer were investigated by autopsy records. Results: We studied 22 men and 25 wo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257395/ https://www.ncbi.nlm.nih.gov/pubmed/35860820 http://dx.doi.org/10.3400/avd.oa.22-00034 |
_version_ | 1784741335475945472 |
---|---|
author | Ro, Ayako Kageyama, Norimasa Mukai, Toshiji |
author_facet | Ro, Ayako Kageyama, Norimasa Mukai, Toshiji |
author_sort | Ro, Ayako |
collection | PubMed |
description | Objective: This study aimed to determine the clinicopathological characteristics of cancer-associated venous thromboembolism (CAT-VTE). Methods: A total of 47 cases of lethal pulmonary thromboembolism (PTE) with active cancer were investigated by autopsy records. Results: We studied 22 men and 25 women who were deceased at a mean age of 66±11 years. Nine (19%) patients had recently undergone cancer resection, 14 (30%) were undergoing clinical treatment for cancer, and 24 (51%) were autopsy-proven CAT-VTE. The colon (eight cases), lungs (seven cases), and ovaries (six cases) were frequent sites of a tumor. There were 29 (62%) cases of acute PTE and 18 (38%) of recurrent PTE. The embolic source was detected in 36/39 (92%) cases. Among them, 33 cases were leg deep vein thrombosis (DVT) and 31 were calf-type DVT. Three cases were isolated vena cava thrombi that were present near the tumor. Twenty-three (64%) cases were recurrent DVT. Conclusion: Most of the lethal CAT-VTE cases were induced by the same mechanism as non-CAT-VTE that originated from calf-type DVT with proximal propagation. However, the finding that patients had tumor-related vena cava thrombi suggested that prevention of CAT-VTE requires individualized treatment of patients according to their pathological condition. (This is secondary publication from Jpn J Phlebol 2020; 31(3): 123–129.) |
format | Online Article Text |
id | pubmed-9257395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92573952022-07-19 Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy Ro, Ayako Kageyama, Norimasa Mukai, Toshiji Ann Vasc Dis Original Article Objective: This study aimed to determine the clinicopathological characteristics of cancer-associated venous thromboembolism (CAT-VTE). Methods: A total of 47 cases of lethal pulmonary thromboembolism (PTE) with active cancer were investigated by autopsy records. Results: We studied 22 men and 25 women who were deceased at a mean age of 66±11 years. Nine (19%) patients had recently undergone cancer resection, 14 (30%) were undergoing clinical treatment for cancer, and 24 (51%) were autopsy-proven CAT-VTE. The colon (eight cases), lungs (seven cases), and ovaries (six cases) were frequent sites of a tumor. There were 29 (62%) cases of acute PTE and 18 (38%) of recurrent PTE. The embolic source was detected in 36/39 (92%) cases. Among them, 33 cases were leg deep vein thrombosis (DVT) and 31 were calf-type DVT. Three cases were isolated vena cava thrombi that were present near the tumor. Twenty-three (64%) cases were recurrent DVT. Conclusion: Most of the lethal CAT-VTE cases were induced by the same mechanism as non-CAT-VTE that originated from calf-type DVT with proximal propagation. However, the finding that patients had tumor-related vena cava thrombi suggested that prevention of CAT-VTE requires individualized treatment of patients according to their pathological condition. (This is secondary publication from Jpn J Phlebol 2020; 31(3): 123–129.) Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2022-06-25 /pmc/articles/PMC9257395/ /pubmed/35860820 http://dx.doi.org/10.3400/avd.oa.22-00034 Text en © 2022 The Editorial Committee of Annals of Vascular Diseases. https://creativecommons.org/licenses/by/2.5/This article is distributed under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided the credit of the original work, a link to the license, and indication of any change are properly given, and the original work is not used for commercial purposes. Remixed or transformed contributions must be distributed under the same license as the original. |
spellingShingle | Original Article Ro, Ayako Kageyama, Norimasa Mukai, Toshiji Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy |
title | Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy |
title_full | Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy |
title_fullStr | Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy |
title_full_unstemmed | Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy |
title_short | Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy |
title_sort | clinicopathological characteristics of cancer-associated venous thromboembolism (cat-vte) from a medicolegal autopsy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257395/ https://www.ncbi.nlm.nih.gov/pubmed/35860820 http://dx.doi.org/10.3400/avd.oa.22-00034 |
work_keys_str_mv | AT roayako clinicopathologicalcharacteristicsofcancerassociatedvenousthromboembolismcatvtefromamedicolegalautopsy AT kageyamanorimasa clinicopathologicalcharacteristicsofcancerassociatedvenousthromboembolismcatvtefromamedicolegalautopsy AT mukaitoshiji clinicopathologicalcharacteristicsofcancerassociatedvenousthromboembolismcatvtefromamedicolegalautopsy |